As usual, the most important info is at the bottom of the article:
Der, who consults for Mirati, cautions that because tumors will likely develop resistance to these KRAS inhibitors, patients will undoubtedly need drug combinations. Still, says Der, who was among those who discovered RAS’s role in cancer in 1982, “I’m excited about these inhibitors. Having been in this field so long, a glimmer of hope is great.”
People get paid by the word.
A cure for cancer will never be found. They don’t want it to be found. Money money money